SCHEMBL16639430

SCHEMBL16639430

CC(=O)Nc1nc(Cl)c(C)c(=O)[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 3/20 0.54
KDM4E B2RXH2 1/20 0.49
GAA P10253 1/20 0.49
GDA Q9Y2T3 1/20 0.48
POLB P06746 2/20 0.46
ALDH1A1 P00352 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
ALOX15 P16050 1/20 0.46
KMT2A Q03164 2/20 0.43
FGFR1 P11362 5/20 0.43
FGFR2 P21802 5/20 0.43
LMNA P02545 1/20 0.41
FGFR3 P22607 2/20 0.41
MEN1 O00255 1/20 0.38
TSHR P16473 1/20 0.38
ADORA2A P29274 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
MAPT P10636 2/20 0.34
BLM P54132 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24802600 0.82 ADORA3 (0.56) ADORA3KDM4EGAAGDAPOLB
SCHEMBL15325124 0.76 GDA (0.43) ADORA3KDM4EGAAGDAPOLB
SCHEMBL16513138 0.71 KDM4E (0.55) ADORA3KDM4EGAAGDAPOLB
SCHEMBL16513137 0.70 GDA (0.64) ADORA3KDM4EGAAGDAPOLB
SCHEMBL11561386 0.70 L3MBTL1 (0.51) ADORA3KDM4EPOLBALDH1A1ALOX15
SCHEMBL28830993 0.70 L3MBTL1 (0.43) ADORA3GAAPOLBALDH1A1TDP1
SCHEMBL3605662 0.69 KDM4E (0.49) ADORA3KDM4EGAAGDAPOLB
SCHEMBL11837884 0.68 POLB (0.48) ADORA3KDM4EGAAGDAPOLB
SCHEMBL216305 0.68 ALDH1A1 (0.48) ADORA3KDM4EGAAGDAPOLB
SCHEMBL4069624 0.68 POLB (0.48) ADORA3KDM4EGAAGDAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9371326-B2 Method for synthesizing sapropterin dihydrochloride ASYMCHEM LABORATORIES (TIANJIN) CO., LTD (CN) 2016-06-21 US disclosed
US-9365573-B2 Method for synthesizing sapropterin dihydrochloride ASYMCHEM LABORATORIES (TIANJIN) CO., LTD (CN) 2016-06-14 US disclosed
US-20150119573-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE TIANJIN ASYMCHEM PHARMACEUTICAL CO., LTD (CN) 2015-04-30 US disclosed
US-20150105555-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE TIANJIN ASYMCHEM PHARMACEUTICAL CO., LTD (CN) 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150105555-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE CYP51A1, DHCR7, LSS ADORA3 3334/4885KDM4E 4409/4885GAA 3185/4885
US-20150119573-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE DHCR7, CYP51A1, HMGCR ADORA3 1512/4885KDM4E 4609/4885GAA 3135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.